Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysis.
- DOI
- 10.1016/j.ejso.2025.111165
- Published
- 2026 Jan
- Container
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejso.2025.111165,
title = {Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysis.},
author = {Andel PCM and van Goor IWJM and Biesma NC and Urban L and Besselink MG and Bonsing BA and Bosscha K and Busch OR and Cirkel GA and van Dam RM and van Eijck CHJ and Festen S and Groot Koerkamp B and van der Harst E and de Hingh IHJT and Intven MPW and Kazemier G and van Laarhoven HWM and Liem MSL and Los M and de Meijer VE and Nieuwenhuijs VB and Roos D and Schreinemakers JMJ and Stommel MWJ and van Tienhoven G and Verdonk RC and de Vos-Geelen J and Wilmink JW and de Wit F and Wumkes ML and Groot VP and van Santvoort HC and Daamen LA and Molenaar IQ and Dutch Pancreatic Cancer Group},
year = {2026},
journal = {European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
doi = {10.1016/j.ejso.2025.111165},
url = {https://doi.org/10.1016/j.ejso.2025.111165}
}RIS
TY - JOUR TI - Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysis. AU - Andel PCM AU - van Goor IWJM AU - Biesma NC AU - Urban L AU - Besselink MG AU - Bonsing BA AU - Bosscha K AU - Busch OR AU - Cirkel GA AU - van Dam RM AU - van Eijck CHJ AU - Festen S AU - Groot Koerkamp B AU - van der Harst E AU - de Hingh IHJT AU - Intven MPW AU - Kazemier G AU - van Laarhoven HWM AU - Liem MSL AU - Los M AU - de Meijer VE AU - Nieuwenhuijs VB AU - Roos D AU - Schreinemakers JMJ AU - Stommel MWJ AU - van Tienhoven G AU - Verdonk RC AU - de Vos-Geelen J AU - Wilmink JW AU - de Wit F AU - Wumkes ML AU - Groot VP AU - van Santvoort HC AU - Daamen LA AU - Molenaar IQ AU - Dutch Pancreatic Cancer Group PY - 2026 JO - European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology DO - 10.1016/j.ejso.2025.111165 UR - https://doi.org/10.1016/j.ejso.2025.111165 ER -
APA
PCM, A., IWJM, V. G., NC, B., L, U., MG, B., BA, B., K, B., OR, B., GA, C., RM, V. D., CHJ, V. E., S, F., B, G. K., E, V. D. H., IHJT, D. H., MPW, I., G, K., HWM, V. L., MSL, L., M, L., VE, D. M., VB, N., D, R., JMJ, S., MWJ, S., G, V. T., RC, V., J, D. V., JW, W., F, D. W., ML, W., VP, G., HC, V. S., LA, D., IQ, M., & Group, D. P. C. (2026). Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysis.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.111165
Source records
- pubmed · retrieved 2026-09-25T02:42:56.593Z